Inventor · disambiguated record
Verney L. Sallee
Also filed as: SALLEE VERNEY L
22 granted patents·2 pending applications·722 citations·filing 1982–2004
97Inventor score
Top patents by PatentIndex Score
24 records- 0195US6184250B1Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertensionALCON LAB INC·Filed 1999·Granted Feb 6, 2001·71 cites·21 claims
- 0294US5889052AUse of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertensionALCON LABORATIES INC·Filed 1997·Granted Mar 30, 1999·181 cites·22 claims
- 0394US5510383AUse of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertensionALCON LAB INC·Filed 1993·Granted Apr 23, 1996·93 cites·20 claims
- 0493US6025392Asubstituted tetrahydrofuran analogs of prostaglandins as ocular hypotensivesALCON LAB INC·Filed 1998·Granted Feb 15, 2000·87 cites·16 claims
- 0586US5480900ACombinations of prostaglandins and clonidine derivatives for the treatment of glaucomaALCON LAB INC·Filed 1995·Granted Jan 2, 1996·50 cites·20 claims
- 0683US5811443ACombinations of prostaglandins and clonidine derivatives for the treatment of glaucomaALCON LAB INC·Filed 1997·Granted Sep 22, 1998·48 cites·13 claims
- 0776US5665773ACloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertensionALCON LAB INC·Filed 1996·Granted Sep 9, 1997·31 cites·20 claims
- 0869US6344478B2Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertensionALCON MFG LTD·Filed 2001·Granted Feb 5, 2002·3 cites·15 claims
- 0967US6353000B111-halo prostaglandins for the treatment of glaucoma or ocular hypertensionALCON LAB INC·Filed 1997·Granted Mar 5, 2002·10 cites·25 claims
- 1065US6723748B2Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertensionALCON MFG LTD·Filed 2002·Granted Apr 20, 2004·2 cites·15 claims
- 1164US2004198817A1Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertensionFiled 2004·Application pending·0 cites
- 1260US5705510AUse of cabergoline and related ergoline derivatives for controlling intraocular pressureALCON LAB INC·Filed 1995·Granted Jan 6, 1998·25 cites·9 claims
- 1359US5605922ACombinations of prostaglandins and clonidine derivatives for the treatment of glaucomaALCON LAB INC·Filed 1995·Granted Feb 25, 1997·11 cites·20 claims
- 1457US4822819AUse of trimoprostil and derivatives in glaucoma therapyALCON LAB INC·Filed 1986·Granted Apr 18, 1989·19 cites·1 claims
- 1556US5173507AProstaglandin combinations in glaucoma therapyALCON LAB INC·Filed 1982·Granted Dec 22, 1992·14 cites·3 claims
- 1654US5565492AProstaglandin combinations in glaucoma therapyALCON LAB INC·Filed 1994·Granted Oct 15, 1996·17 cites·18 claims
- 1753US4822820AUse of tri-methyl PG-F2 a and derivatives in glaucoma therapyALCON LAB INC·Filed 1986·Granted Apr 18, 1989·16 cites·1 claims
- 1849US5721273AUse of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertensionALCON LAB INC·Filed 1993·Granted Feb 24, 1998·10 cites·9 claims
- 1947US6166073ACombinations of DP and FP type prostaglandins for lowering IOPALCON LAB INC·Filed 1999·Granted Dec 26, 2000·9 cites·16 claims
- 2047US5700835A3-Oxa-D-prostaglandins for lowering IOPALCON LAB INC·Filed 1995·Granted Dec 23, 1997·9 cites·8 claims
- 2146US2003212107A1R-reliprodil for treating glaucomaFiled 2001·Application pending·0 cites
- 2245US6353014B115-ketal postaglandins for the treatment of glaucoma or ocular hypertensionALCON LAB INC·Filed 1997·Granted Mar 5, 2002·8 cites·20 claims
- 2344US5627209AUse of certain 9-haloprostaglandins to treat glaucoma and ocular hypertensionALCON LAB INC·Filed 1995·Granted May 6, 1997·7 cites·7 claims
- 2437US6197812B1Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensivesALCON LAB INC·Filed 1999·Granted Mar 6, 2001·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Verney L. Sallee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →